Profil
Mitchell Barneck is the founder of Light Line Medical, Inc. He held the title of Director & Vice President-Clinical Affairs at the company.
Aktive Positionen von Mitchell Barneck
Unternehmen | Position | Beginn |
---|---|---|
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Light Line Medical, Inc.
Light Line Medical, Inc. Medical SpecialtiesHealth Technology Light Line Medical, Inc. is a medical company based in an undisclosed location. Light Line Medical has developed a patented, non-invasive visible light platform to prevent catheter-associated infections. The technology uses safe visible light emitted through a fiber optic cable to disinfect and protect the inside and outside of the catheter, killing microbes and preventing infection without relying on drugs, chemicals, or harmful UV light. The American company's published international patent portfolio includes 23 issued patents and 16 pending patent applications. The technology is effective in preventing infections in dialysis, urinary/Foley, respiratory/endotracheal, and vascular catheter use. The company was founded by Mitchell Barneck and has been led by CEO Vicki E. Farrar since 2017. | Health Technology |